Risk of 30-day hospital readmission associated with medical conditions and drug regimens of polymedicated, older inpatients discharged home: a registry-based cohort study.
clinical pharmacology
epidemiology
geriatric medicine
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
14 07 2021
14 07 2021
Historique:
entrez:
15
7
2021
pubmed:
16
7
2021
medline:
5
8
2021
Statut:
epublish
Résumé
The present study analysed 4 years of a hospital register (2015-2018) to determine the risk of 30-day hospital readmission associated with the medical conditions and drug regimens of polymedicated, older inpatients discharged home. Registry-based cohort study. Valais Hospital-a public general hospital centre in the French-speaking part of Switzerland. We explored the electronic records of 20 422 inpatient stays by polymedicated, home-dwelling older adults held in the hospital's patient register. We identified 13 802 hospital readmissions involving 8878 separate patients over 64 years old. Sociodemographic characteristics, medical conditions and drug regimen data associated with risk of readmission within 30 days of discharge. The overall 30-day hospital readmission rate was 7.8%. Adjusted multivariate analyses revealed increased risk of hospital readmission for patients with longer hospital length of stay (OR=1.014 per additional day; 95% CI 1.006 to 1.021), impaired mobility (OR=1.218; 95% CI 1.039 to 1.427), multimorbidity (OR=1.419 per additional International Classification of Diseases, 10th Revision condition; 95% CI 1.282 to 1.572), tumorous disease (OR=2.538; 95% CI 2.089 to 3.082), polypharmacy (OR=1.043 per additional drug prescribed; 95% CI 1.028 to 1.058), and certain specific drugs, including antiemetics and antinauseants (OR=3.216 per additional drug unit taken; 95% CI 1.842 to 5.617), antihypertensives (OR=1.771; 95% CI 1.287 to 2.438), drugs for functional gastrointestinal disorders (OR=1.424; 95% CI 1.166 to 1.739), systemic hormonal preparations (OR=1.207; 95% CI 1.052 to 1.385) and vitamins (OR=1.201; 95% CI 1.049 to 1.374), as well as concurrent use of beta-blocking agents and drugs for acid-related disorders (OR=1.367; 95% CI 1.046 to 1.788). Thirty-day hospital readmission risk was associated with longer hospital length of stay, health disorders, polypharmacy and drug regimens. The drug regimen patterns increasing the risk of hospital readmission were very heterogeneous. Further research is needed to explore hospital readmissions caused solely by specific drugs and drug-drug interactions.
Identifiants
pubmed: 34261693
pii: bmjopen-2021-052755
doi: 10.1136/bmjopen-2021-052755
pmc: PMC8281082
doi:
Substances chimiques
Pharmaceutical Preparations
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e052755Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Expert Opin Drug Saf. 2014 Jan;13(1):57-65
pubmed: 24073682
Br J Clin Pharmacol. 2009 Jun;67(6):641-5
pubmed: 19594531
Integr Pharm Res Pract. 2020 Apr 02;9:71-81
pubmed: 32309200
PLoS Med. 2015 Oct 06;12(10):e1001885
pubmed: 26440803
PLoS One. 2019 Jul 15;14(7):e0219348
pubmed: 31306461
Psychiatry Res. 2020 Sep;291:113168
pubmed: 32619823
Clin Orthop Relat Res. 2020 Feb;478(2):231-237
pubmed: 31688209
Indian J Psychiatry. 2017 Oct-Dec;59(4):524-525
pubmed: 29497207
Expert Opin Drug Saf. 2018 Dec;17(12):1185-1196
pubmed: 30540223
Ann Pharmacother. 2019 Jan;53(1):28-34
pubmed: 30070583
J Am Geriatr Soc. 2003 Apr;51(4):451-8
pubmed: 12657063
Arch Intern Med. 2008 Sep 22;168(17):1890-6
pubmed: 18809816
Value Health. 2011 Jan;14(1):34-40
pubmed: 21211484
Br J Clin Pharmacol. 2010 Nov;70(5):749-55
pubmed: 21039769
JAMA Intern Med. 2015 Apr;175(4):559-65
pubmed: 25642907
BMJ Open. 2018 Aug 29;8(8):e019192
pubmed: 30158214
N Engl J Med. 2014 Mar 27;370(13):1198-208
pubmed: 24670166
CMAJ. 2018 Sep 24;190(38):E1124-E1133
pubmed: 30249758
BMJ. 2018 Feb 27;360:k497
pubmed: 29487063
JMIR Med Inform. 2021 May 11;9(5):e24205
pubmed: 33973865
Int J Clin Pharmacol Ther. 2007 Dec;45(12):643-53
pubmed: 18184532
PLoS One. 2020 Jun 30;15(6):e0233457
pubmed: 32603361
Pharmacotherapy. 2013 Aug;33(8):827-37
pubmed: 23686895
Int J Clin Pharm. 2020 Oct;42(5):1243-1251
pubmed: 32472324
Clin Interv Aging. 2016 Jun 23;11:857-66
pubmed: 27382268
J Am Geriatr Soc. 2013 Jan;61(1):113-21
pubmed: 23252914
Med Care. 2019 Apr;57(4):295-299
pubmed: 30829940
Nord J Psychiatry. 2019 Jan;73(1):73-79
pubmed: 30661437
Patient Educ Couns. 2019 Aug;102(8):1513-1519
pubmed: 30987768
J Geriatr Oncol. 2020 Sep;11(7):1108-1114
pubmed: 32222347
Health Place. 2019 Nov;60:102230
pubmed: 31634701
BMJ Open. 2019 Nov 19;9(11):e031369
pubmed: 31748302
Am J Cardiol. 2017 Mar 1;119(5):760-769
pubmed: 28109560
Pharm Pract (Granada). 2012 Oct;10(4):207-21
pubmed: 24155839
PLoS One. 2018 Sep 13;13(9):e0203375
pubmed: 30212485
BMJ. 2020 Jun 18;369:m2023
pubmed: 32554409
JACC Heart Fail. 2017 Aug;5(8):578-588
pubmed: 28501521
Eur J Clin Pharmacol. 2016 May;72(5):631-9
pubmed: 26884320
BMJ. 2013 Dec 16;347:f7171
pubmed: 24342737
Proc (Bayl Univ Med Cent). 2008 Oct;21(4):363-72
pubmed: 18982076
Health Care Manag Sci. 2015 Mar;18(1):19-34
pubmed: 24792081
Ageing Res Rev. 2011 Sep;10(4):430-9
pubmed: 21402176
Patient Prefer Adherence. 2017 Apr 20;11:801-810
pubmed: 28461742
BMC Geriatr. 2017 Oct 10;17(1):230
pubmed: 29017448
BMJ. 2013 Nov 20;347:f6571
pubmed: 24259033
BMC Health Serv Res. 2017 Jul 4;17(1):458
pubmed: 28676090
Arch Intern Med. 2005 Sep 12;165(16):1842-7
pubmed: 16157827
J Am Geriatr Soc. 2011 May;59(5):948-9
pubmed: 21568972
BMJ Open. 2019 Oct 28;9(10):e030030
pubmed: 31662367
JAMA Netw Open. 2019 Sep 4;2(9):e1912208
pubmed: 31560381
Chest. 2016 Apr;149(4):1021-9
pubmed: 26836926
BMC Fam Pract. 2018 Jul 18;19(1):113
pubmed: 30021528
Br J Clin Pharmacol. 2015 Oct;80(4):796-807
pubmed: 25619317
BJPsych Bull. 2015 Jun;39(3):119-23
pubmed: 26191449
J Am Pharm Assoc (2003). 2017 Nov - Dec;57(6):711-716
pubmed: 28823545
Ann Intern Med. 2003 Feb 4;138(3):161-7
pubmed: 12558354
BMJ. 2009 Jan 07;338:a2752
pubmed: 19129307
Int J Environ Res Public Health. 2020 Apr 30;17(9):
pubmed: 32365917
BMJ Open. 2019 Jul 29;9(7):e028302
pubmed: 31362964
Ann Fam Med. 2009 Jul-Aug;7(4):357-63
pubmed: 19597174
Pharmacotherapy. 2006 Nov;26(11):1578-86
pubmed: 17064202
J Am Geriatr Soc. 2018 Mar;66(3):602-608
pubmed: 29468640
J Eval Clin Pract. 2017 Apr;23(2):391-401
pubmed: 27576302
N Engl J Med. 2009 Apr 2;360(14):1418-28
pubmed: 19339721
J Womens Health (Larchmt). 2014 Feb;23(2):112-9
pubmed: 24206025
Dement Geriatr Cogn Dis Extra. 2017 Oct 19;7(3):346-353
pubmed: 29282407
Ann Intern Med. 2011 Oct 18;155(8):520-8
pubmed: 22007045
Scand J Public Health. 2011 May;39(3):225-9
pubmed: 21427148
J Pharmacol Pharmacother. 2013 Apr;4(2):91-4
pubmed: 23761706
J Geriatr Oncol. 2015 Jul;6(4):254-61
pubmed: 25976445
N Engl J Med. 2017 Sep 14;377(11):1055-1064
pubmed: 28902587
Rev Saude Publica. 2012 Dec;46(6):1082-9
pubmed: 23358622